Prevalence and management of hypertension in Turner syndrome: data from the International Turner Syndrome (I-TS) registry
- PMID: 39773908
- PMCID: PMC11770400
- DOI: 10.1530/EC-24-0477
Prevalence and management of hypertension in Turner syndrome: data from the International Turner Syndrome (I-TS) registry
Abstract
Introduction: Cardiovascular disease is the most common cause of death in Turner syndrome (TS) for which arterial hypertension has a direct influence and is a key modifiable risk factor.
Objective: To investigate the prevalence and patterns of hypertension diagnosis and management in adult patients with TS who are registered in a large international multicentre database (TS-HTN study).
Methods: Retrospective multicentre observational study of patients aged ≥18 years included in the I-TS (International-TS) registry (2020-2022), using registry and participating centre-collected data.
Results: Twelve international centres participated, including 182 patients with a median age of 28 years (IQR 23-37.2). Arterial hypertension was recorded in 13.2% (n = 24). The median age at hypertension diagnosis was 27 years (range 10-56), with 92% aged less than 50 years at diagnosis. The majority (75%) were classified as primary hypertension (n = 18). In binomial regression analysis, higher body mass index was the only parameter significantly associated with the occurrence of hypertension (B = 1.487, P = 0.004). Among patients with aortic disease (n = 9), 50% had systolic BP ≥ 130 mmHg and 66.6% had diastolic BP ≥ 80 mmHg during the last clinic review. Angiotensin-converting enzyme inhibitors were the most common (n = 16) medication prescribed, followed by angiotensin receptor blockers (n = 6), beta-blockers (n = 6) and calcium channel blockers (n = 6).
Conclusions: Arterial hypertension is common in TS and occurs at a young age. Overweight/obesity was a notable risk factor for hypertension. The frequency of suboptimal BP control among high-risk patients highlights the importance of increased awareness and TS-specific consensus guidance on management.
Keywords: International Turner Syndrome Registry; Turner syndrome; hypertension.
Conflict of interest statement
The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of this work.
Figures


Similar articles
-
Relationship between systolic hypertension assessed by 24-hour ambulatory blood pressure monitoring and aortic diameters in young women with Turner syndrome.Clin Endocrinol (Oxf). 2019 Jul;91(1):156-162. doi: 10.1111/cen.13995. Epub 2019 Apr 30. Clin Endocrinol (Oxf). 2019. PMID: 31001842
-
Blood pressure and Turner syndrome.Clin Endocrinol (Oxf). 2000 Mar;52(3):363-70. doi: 10.1046/j.1365-2265.2000.00960.x. Clin Endocrinol (Oxf). 2000. PMID: 10718835
-
Clinical assessment of blood pressure in 60 girls with Turner syndrome compared to 1888 healthy Danish girls.Clin Endocrinol (Oxf). 2022 Mar;96(3):428-438. doi: 10.1111/cen.14669. Epub 2022 Jan 7. Clin Endocrinol (Oxf). 2022. PMID: 34995381
-
Hypertension in Children and Adolescents with Turner Syndrome (TS), Neurofibromatosis 1 (NF1), and Williams Syndrome (WS).Curr Hypertens Rep. 2021 Mar 29;23(4):18. doi: 10.1007/s11906-021-01136-7. Curr Hypertens Rep. 2021. PMID: 33779870 Review.
-
Cardiometabolic and vascular risks in young and adolescent girls with Turner syndrome.BBA Clin. 2015 Apr 30;3:304-9. doi: 10.1016/j.bbacli.2015.04.005. eCollection 2015 Jun. BBA Clin. 2015. PMID: 26673162 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources